Rosenstock J - Search Results

1

Switching to Once-Weekly Insulin Icodec Versus Once-Daily Insulin Glargine U100 in Type 2 Diabetes Inadequately Controlled on Daily Basal Insulin: A Phase 2 Randomized Controlled Trial.

Bajaj HS, Bergenstal RM, Christoffersen A, Davies MJ, Gowda A, Isendahl J, Lingvay I, Senior PA, Silver RJ, Trevisan R, Rosenstock J. Bajaj HS, et al. Among authors: rosenstock j. Diabetes Care. 2021 Jul;44(7):1586-1594. doi: 10.2337/dc20-2877. Epub 2021 Apr 19. Diabetes Care. 2021. PMID: 33875485 Free PMC article. Clinical Trial.

2

The treat-to-target trial: randomized addition of glargine or human NPH insulin to oral therapy of type 2 diabetic patients.

Riddle MC, Rosenstock J, Gerich J; Insulin Glargine 4002 Study Investigators. Riddle MC, et al. Among authors: rosenstock j. Diabetes Care. 2003 Nov;26(11):3080-6. doi: 10.2337/diacare.26.11.3080. Diabetes Care. 2003. PMID: 14578243 Clinical Trial.

3

Basal insulin supplementation in type 2 diabetes; refining the tactics.

Rosenstock J. Rosenstock J. Am J Med. 2004 Feb 2;116 Suppl 3A:10S-16S. doi: 10.1016/j.amjmed.2003.12.004. Am J Med. 2004. PMID: 15013455 Review.

4

Patient satisfaction and glycemic control after 1 year with inhaled insulin (Exubera) in patients with type 1 or type 2 diabetes.

Rosenstock J, Cappelleri JC, Bolinder B, Gerber RA. Rosenstock J, et al. Diabetes Care. 2004 Jun;27(6):1318-23. doi: 10.2337/diacare.27.6.1318. Diabetes Care. 2004. PMID: 15161782

5

Insulin glulisine provides improved glycemic control in patients with type 2 diabetes.

Dailey G, Rosenstock J, Moses RG, Ways K. Dailey G, et al. Among authors: rosenstock j. Diabetes Care. 2004 Oct;27(10):2363-8. doi: 10.2337/diacare.27.10.2363. Diabetes Care. 2004. PMID: 15451901 Clinical Trial.

6

Reduced hypoglycemia risk with insulin glargine: a meta-analysis comparing insulin glargine with human NPH insulin in type 2 diabetes.

Rosenstock J, Dailey G, Massi-Benedetti M, Fritsche A, Lin Z, Salzman A. Rosenstock J, et al. Diabetes Care. 2005 Apr;28(4):950-5. doi: 10.2337/diacare.28.4.950. Diabetes Care. 2005. PMID: 15793205

7

Counterpoint: Inpatient glucose management: a premature call to arms?

Inzucchi SE, Rosenstock J. Inzucchi SE, et al. Among authors: rosenstock j. Diabetes Care. 2005 Apr;28(4):976-9. doi: 10.2337/diacare.28.4.976. Diabetes Care. 2005. PMID: 15793210 Review. No abstract available.

8

Effects of exenatide (exendin-4) on glycemic control over 30 weeks in patients with type 2 diabetes treated with metformin and a sulfonylurea.

Kendall DM, Riddle MC, Rosenstock J, Zhuang D, Kim DD, Fineman MS, Baron AD. Kendall DM, et al. Among authors: rosenstock j. Diabetes Care. 2005 May;28(5):1083-91. doi: 10.2337/diacare.28.5.1083. Diabetes Care. 2005. PMID: 15855571 Clinical Trial.

9

Inhaled insulin improves glycemic control when substituted for or added to oral combination therapy in type 2 diabetes: a randomized, controlled trial.

Rosenstock J, Zinman B, Murphy LJ, Clement SC, Moore P, Bowering CK, Hendler R, Lan SP, Cefalu WT. Rosenstock J, et al. Ann Intern Med. 2005 Oct 18;143(8):549-58. doi: 10.7326/0003-4819-143-8-200510180-00005. Ann Intern Med. 2005. PMID: 16230721 Clinical Trial.

10

Triple therapy in type 2 diabetes: insulin glargine or rosiglitazone added to combination therapy of sulfonylurea plus metformin in insulin-naive patients.

Rosenstock J, Sugimoto D, Strange P, Stewart JA, Soltes-Rak E, Dailey G. Rosenstock J, et al. Diabetes Care. 2006 Mar;29(3):554-9. doi: 10.2337/diacare.29.03.06.dc05-0695. Diabetes Care. 2006. PMID: 16505505 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

529 results

Search Page